Inhibition of the renin-angiotensin system and the left ventricular adaptation to mitral regurgitation.
Gaasch
William H
WH
Aurigemma
Gerard P
GP
D000804:Angiotensin II / Q000097:blood / Q000187:drug effects; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000188:drug therapy / Q000503:physiopathology*; D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000502:physiology*; D012720:Severity of Illness Index; D014665:Vasodilator Agents / Q000627:therapeutic use; D016277:Ventricular Function, Left / Q000502:physiology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin; D014665:Vasodilator Agents; D000804:Angiotensin II